Benjamin Solomon
Impact in
- Pulmonary and Respiratory Medicine top 0.02%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 0.05%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
Papers in
-
- Lung Cancer Treatments and Mutations 248
- Lung Cancer Diagnosis and Treatment 71
- Gastric Cancer Management and Outcomes 17
- Oncology 217
- Colorectal Cancer Treatments and Studies 82
- Lung Cancer Research Studies 77
- Cancer Immunotherapy and Biomarkers 41
- Co-authors
- Alice T. Shaw (82 shared papers)Rebecca S. Heist (6 shared papers)Lecia V. Sequist (16 shared papers)Justin F. Gainor (8 shared papers)Enriqueta Felip (74 shared papers)Tony Mok (37 shared papers)Keith D. Wilner (29 shared papers)Alesha Thai (3 shared papers)
- Journals
- Journal of Clinical Oncology (87 papers)Annals of Oncology (56 papers)Journal of Thoracic Oncology (44 papers)Lung Cancer (13 papers)Cancer Research (12 papers)
- Partner nations
- AustraliaUnited StatesFrance
In The Last Decade
Benjamin Solomon
401 papers receiving 21.8k citations
Benjamin Solomon's Hit Papers
Peers
Comparison fields: 5 of 149
- Pulmonary and Respiratory Medicine 13.1k
- Oncology 9.8k
- Cancer Research 3.4k
- Otorhinolaryngology 884
- Molecular Biology 5.8k
Countries citing papers authored by Benjamin Solomon
This map shows the geographic impact of Benjamin Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Solomon more than expected).
Fields of papers citing papers by Benjamin Solomon
This network shows the impact of papers produced by Benjamin Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Solomon. The network helps show where Benjamin Solomon may publish in the future.
Co-authors
The 25 scholars most cited alongside Benjamin Solomon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 416 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer Hit paper breakdown → | 2014 | 2407 |
| 2 | Lung cancer Hit paper breakdown → | 2021 | 1691 |
| 3 | Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK Hit paper breakdown → | 2009 | 1517 |
| 4 | Mechanisms of Acquired Crizotinib Resistance in ALK-Rearranged Lung Cancers Hit paper breakdown → | 2012 | 1014 |
| 5 | First-Line Lorlatinib or Crizotinib in Advanced ALK -Positive Lung Cancer Hit paper breakdown → | 2020 | 683 |
| 6 | Prognostic Significance of p16 INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial Hit paper breakdown → | 2010 | 595 |
| 7 | Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial Hit paper breakdown → | 2017 | 506 |
| 8 | Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases Hit paper breakdown → | 2015 | 491 |
| 9 | Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2023 | 414 |
| 10 | Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial Hit paper breakdown → | 2019 | 389 |
| 11 | Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 Hit paper breakdown → | 2019 | 379 |
| 12 | 2011 | 360 | |
| 13 | 2011 | 351 | |
| 14 | Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments Hit paper breakdown → | 2018 | 344 |
| 15 | Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Hit paper breakdown → | 2023 | 322 |
| 16 | Final Overall Survival Analysis From a Study Comparing First-Line Crizotinib Versus Chemotherapy in ALK-Mutation-Positive Non–Small-Cell Lung Cancer Hit paper breakdown → | 2018 | 295 |
| 17 | 2019 | 279 | |
| 18 | 2009 | 274 | |
| 19 | Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial Hit paper breakdown → | 2019 | 261 |
| 20 | 2011 | 243 |
About Benjamin Solomon
Benjamin Solomon is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 416 papers that have together received 22.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (248 papers), Colorectal Cancer Treatments and Studies (82 papers), Lung Cancer Research Studies (77 papers), Lung Cancer Diagnosis and Treatment (71 papers), Cancer Genomics and Diagnostics (51 papers), Cancer Immunotherapy and Biomarkers (41 papers), Head and Neck Cancer Studies (23 papers) and Gastric Cancer Management and Outcomes (17 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (13.1k citations), Oncology (9.8k citations), Cancer Research (3.4k citations), Otorhinolaryngology (884 citations) and Molecular Biology (5.8k citations). Benjamin Solomon has collaborated with scholars based in Australia, United States and France. Frequent co-authors include Alice T. Shaw, Rebecca S. Heist, Lecia V. Sequist, Justin F. Gainor, Enriqueta Felip, Tony Mok, Keith D. Wilner, Alesha Thai, D. Ross Camidge and A. John Iafrate. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.